GENESIS Pharma receives its 3rd Gold Award and a special distinction for its social contribution in the CR Index
For the third consecutive year, GENESIS Pharma received a gold award for its overall performance in corporate responsibility while this year the company was honored with a special distinction for its social contribution in the Greek Corporate Responsibility Index.
The company was also awarded by the Greek Institute for Corporate Responsibility for its commitment to corporate responsibility and its long-term presence in the Greek Corporate Responsibility Index, becoming one out of the three companies in Greece to receive such a distinction.
GENESIS Pharma was the first pharmaceutical company in Greece that participated and excelled in the CR Index back in 2009 and has been constantly improving its performance ever since. The awards that the company has received over the years underline its long-term commitment to Corporate Responsibility and the strong relations that has built with its stakeholders based on shared value and transparency.
The integrated programme of corporate responsibility and excellence developed by GENESIS Pharma sets as priorities the high quality of services and products, the access of patients in their treatment, the good working environment, the responsible environmental policy and a social contribution towards vulnerable groups and the young generation. It is a commitment that involves all employees and becomes stronger each year, with new policies and actions that address the expectations/respond to the expectations of health professionals, employees and the society at large.